000 01301 a2200397 4500
005 20250512022516.0
264 0 _c19890316
008 198903s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1988.277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBermudez, J
245 0 0 _aThe anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
_h[electronic resource]
260 _bBritish journal of cancer
_cNov 1988
300 _a644-50 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aApomorphine
_xadverse effects
650 0 4 _aCisplatin
_xadverse effects
650 0 4 _aCyclophosphamide
_xadverse effects
650 0 4 _aDogs
650 0 4 _aDoxorubicin
_xadverse effects
650 0 4 _aFerrets
650 0 4 _aGranisetron
650 0 4 _aIndazoles
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aPyrazoles
_xtherapeutic use
650 0 4 _aTriazines
_xadverse effects
650 0 4 _aVomiting
_xdrug therapy
650 0 4 _aWhole-Body Irradiation
700 1 _aBoyle, E A
700 1 _aMiner, W D
700 1 _aSanger, G J
773 0 _tBritish journal of cancer
_gvol. 58
_gno. 5
_gp. 644-50
856 4 0 _uhttps://doi.org/10.1038/bjc.1988.277
_zAvailable from publisher's website
999 _c2857174
_d2857174